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Introduction and Purpose:  
Vascular pathologies play an important role in the etiology and progression of number of ocular 
diseases. Many instruments are developed to monitor retinal hemodynamics, including the 
Canon Laser Blood Flowmeter (CLBF), in an attempt to better understand the pathophysiology 
of the disease (Chapter 2). The purpose of this thesis is to determine the impact of light scatter on 
retinal arteriolar hemodynamic measurement assessed by the CLBF as intraocular light scatter is 
an inevitable consequence of ageing and particularly cataract.  
 
Methodology:  
Chapter 4 – Artificial light scatter model: One eye from each of 10 healthy young subjects 
between the ages of 18 and 30 (23.6 ± 3.4) was randomly selected. To simulate light scatter, cells 
comprising a plastic collar and two plano lenses were filled with solutions of differing 
concentrations of polystyrene microspheres (Polysciences Inc., USA). 0.002%, 0.004%, 0.006%, 
0.008% were prepared, as well as distilled water only. After a preliminary screening to confirm 
subject eligibility, seven arteriolar hemodynamic measurements were taken by randomly placing 
the cells between the CLBF objective lens and the subjects’ cornea. 
 
Chapter 5 – Ten patients scheduled for extracapsular cataract extraction using 
phacoemulsification and intraocular lens implantation between the ages of 61 and 84 (mean age 
73 years, SD ± 8) were prospectively recruited. Two visits were required to complete the study; 
One prior to the surgery and one at least six weeks after the surgery to allow for full post-
operative recovery. The severity of cataract was documented using the Lens Opacity 
Classification System (LOCS, III) at the first visit. Each subject underwent visual function 
assessment at both visits using logMAR Early Treatment Diabetic Retinopathy Study (ETDRS) 
visual acuity charts and the Brightness Acuity Tester (BAT). Retinal arteriolar hemodynamics 






Chapter 4: Our light scatter model resulted in an artifactual increase of retinal arteriolar diameter 
(p<0.0001) and thereby increased retinal blood flow (p<0.0001). The 0.006% and 0.008% 
microsphere concentrations produced significantly higher diameter and flow values than 
baseline. Centerline blood velocity, however, was not affected by light scatter.  Retinal arteriolar 
diameter values were significantly less with the high intensity laser than with the low intensity 
laser (p=0.0007). 
 
Chapter 5: Group mean retinal arteriolar diameter and blood flow were reduced following 
extracapsular cataract extraction (Wilcoxon signed-rank test, p=0.022 and p=0.028 respectively); 
however, centerline blood velocity was unchanged (Wilcoxon signed-rank test, p=0.074).    
   
Conclusions:  
Using an artificial light scatter model (Chapter 3), we demonstrated that the densitometry 
assessment of vessel diameter is increasingly impacted as the magnitude of artificial light scatter 
increases; this effect can be partially negated by increasing laser intensity. We showed similar 
results in the presence of cataract (Chapter 4) by measuring the retinal arteriolar hemodynamics 
before and after removal of cataract. Care needs to be exercised in the interpretation of studies of 
retinal vessel diameter that use similar densitometry techniques as cataract is an inevitable 
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Two separate vascular systems are involved in the ocular blood circulation; Retinal and uveal 
(ciliary) blood vessels.  The uveal blood vessels include the vascular beds of the iris, the ciliary 
body, and the choroid1.   
Arising from the ophthalmic artery within the orbit, the central retinal artery (CRA) supplies 
approximately the inner 2/3 of the retina. The CRA pierces the optic nerve approximately 10-15 
mm behind the globe, running parallel with the central retinal vein within the optic nerve2. It 
passes through the lamina cribrosa entering the optic disc just nasal to center and branches 
superiorly and inferiorly. These branches divide into nasal and temporal branches, and continue 
to bifurcate within the retinal nerve fiber layer below the transparent internal limiting membrane 
to supply the quadrants of the retina3. The tight junctions between the endothelial cells (zonula 
occludens) constitute the inner blood retinal barrier (BRB), preventing leakage of blood 
constituents into the retinal tissue for optimal retinal functioning. 
The outer 1/3 of the retina, including the photoreceptors, is avascular and nourished from the 
highly vascularized choroidal circulation, derived from the ophthalmic artery via branches of the 
long posterior ciliary, short posterior ciliary, and anterior ciliary arteries. Specifically, the short 
posterior ciliary arteries supply the posterior choroid, while the long posterior ciliary arteries and 
anterior ciliary arteries supply the anterior choroid and the circle of the iris4. The anatomical 
border between the retina and the choroid is Bruch’s membrane5. Adjacent to Bruch’s 
membrane, the retinal pigment epithelium (RPE), acts as the blood-retina barrier and selectively 
transports nutrients and waste between the choriocapillaris and the neural retina6. The fovea 
centralis is completely avascular in terms of the inner retinal blood supply and totally relies upon 
the underlying choroid for metabolic supply and waste removal2.  
The veins of the orbit are tortuous and freely anastomose with one another and they have no 
valves or sphincters.  The orbit is drained by the superior and inferior ophthalmic veins, which in 
turn drain directly into the cavernous sinus. The central retinal vein usually drains directly into 
the cavernous sinus or into the superior ophthalmic vein4. 
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1.2 Retinal Blood Flow 
Blood flow through a vessel is dependent on perfusion pressure and resistance to flow. Perfusion 
pressure is the difference between local arterial (Pa) and venous pressures. In the eye, venous 
pressure is assumed to be equal to intraocular pressure (IOP). Blood flow in the retinal vessels is 
consistent with Poiseuille’s law of laminar flow7-11.  
 
1.2.1 Poiseuille’s Law 
Poiseuille’s law states that in the case of smooth flow (laminar flow), the volume flow rate is 
given by the pressure difference divided by the viscous resistance. The resistance to blood flow 
is inversely proportional to the fourth power of the radius of the vessel and directly proportional 
to blood viscosity and the length of the vessel7;11;12.  Poiseuille's law is found to be in reasonable 
agreement with experiments on uniform liquids (called Newtonian fluids) in cases where there is 
















 is the pressure drop per unit length of blood vessel, η is the blood viscosity, and D 
is the blood column diameter. 
 
1.2.2 Autoregulation of Blood Flow 
The goal of autoregulation in a tissue is to maintain relatively constant blood flow, capillary 
pressure, and nutrient supply, despite changes in perfusion pressure (mean arterial BP in vessels 
– IOP).  Autoregulation of blood flow is achieved by alteration in resistance to blood flow and 
that in turn is affected by change in the diameter of the blood vessels.  It is generally thought that 
the terminal arterioles regulate the resistance to flow, i.e. they dilate to increase the blood flow 
when the perfusion pressure falls and constrict to reduce the blood flow in arterial hypertension.  
Since there is a limit to how far the terminal arterioles can constrict or dilate, the autoregulation 
operates only within a certain critical range of perfusion pressure, and breaks down when the 
perfusion pressure goes below or above this critical range11.   
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It is well known that retinal blood flow has an efficient autoregulation11. The choroid on the 
other hand is richly supplied by the autonomic nerves which are mainly responsible for vascular 
resistance.  Recent studies have shown a modest autoregulation in the subfoveal choroid2;13-15. 
 
According to the metabolic hypothesis, local arteriolar smooth muscle tone is also regulated by 
the local concentration of metabolic products, pO2 and pCO216-18. Conversely, the myogenic 
hypothesis states that rise of perfusion pressure causes vasoconstriction because stretching of the 
vessel wall is counteracted by vasoconstriction in the arterioles19. Endothelial derived vasoactive 
agents (Prostanoids, NO, endothelins, angiotensins, thromboxane A2, etc.) are thought to be most 
probably responsible for initiating both the metabolic and myogenic contraction. Based on the 
neurogenic hypothesis, autoregulation is carried out by neural input in the vessels.  This 
hypothesis is more relevant to the choroidal autoregulation as retinal blood vessels lack an 
autonomous innervation.  
 
1.2.3 Blood Flow and Ocular Diseases 
A mounting body of evidence suggests that vascular pathologies play an important role in the 
etiology and progression of number of ophthalmic diseases, including glaucoma, age-related 
macular degeneration, and diabetic retinopathy2;20;21. Our laboratory has shown reduced retinal 
vascular reactivity in diabetic patients22-25. Studies in glaucoma patients have shown reduced 
blood flow to the retinal ganglion cells and optic nerve, possibly contributing to the damage seen 
in glaucomatous optic neuropathy21;26;27. Changes in macular retinal capillary blood flow are also 
documented in age-related maculopathy28. In the future, the assessment of ocular hemodynamics 
may play a role in the early detection of some of the ocular diseases and possibly provide new 
insight of retinal disease that may offer new treatment options. Other possible uses are 
monitoring disease progression and evaluating the effectiveness of surgical and drug treatments.    
  
1.3 Ocular Hemodynamic Assessment Techniques 
The eye is the only location in the human body that allows for a direct, noninvasive observation 
of vascular blood flow.  In this respect, the eye provides us with a unique opportunity to study 





The pulsatile ocular blood flow device is a pneumotonometer that measures IOP in real time.  
The underlying concept is that IOP increases as the blood volume in the eye increases with the 
systolic pulse and decreases as the eye blood volume decreases during diastole.  These 
fluctuations are then recorded as a function of time which is then transformed into volume 
fluctuations over time. Calculation of pulsatile ocular blood flow from the change in IOP is 
based upon a model eye assuming a standard ocular rigidity29-31. One of the weaknesses of this 
particular technique is that a universal relationship is used to convert IOP pulse wave into an 
ocular blood volume wave and the considerable individual variation in this relationship is 
ignored2.  Some of the advantages are the affordable price of this device and that it is easy to 
operate. 
 
Interferometry32 is another technique used to directly measure the pulsation of the fundus relative 
to the cornea2.  A single laser beam passes through the center of the eye and partially reflects 
from both cornea and retina.  These two reflections form a stationary interference pattern which 
is a function of the distance between the two reflective sources2;21.  The advantage of the 
interferometry is that it uses absolute units in micrometers to measure fundus movement.  
Excellent reproducibility is another major advantage of this technique.  However, all pulsatility 
based measurement devices measure the secondary effects of blood flow upon some aspect of the 
eye and not the blood flow itself.  
 
1.3.2 Angiography 
Fluorescein dye was first used to assess retinal blood flow quantitatively by Hickam and 
Frayser33. Measurement of ocular hemodynamics by angiography is based on a dye dilution 
technique, where a known amount of a dye (or indicator) is injected into a vein and its 
arteriovenous passage time is observed at different points21;34.  The concentration of the dye 
within the blood at an observation point is graphed against time and is called dye dilution curve.  
This technique is based on the concept that: Dye Flow Rate = Blood Flow rate x ([Ip]-[Id]), where 
[Ip]-[Id] is the difference between the concentration of the indicator or dye proximal and distal to 
the area of the measurement34. 
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Over the past decade, scanning laser ophthalmoscopes with confocal optics have improved the 
quality of images and allow high temporal resolution imaging. Two devices are currently 
commercially available, the Heidelberg Retina Angiograph (HRA) system and the Rodenstock 
scanning laser ophthalmoscope (SLO).   
 
Fluorescence angiography is invasive and is not a good technique to assess patients in the later 
stages of retinopathy as vessels might leak the fluorescein and the visualisation of the dye 
becomes more difficult35.  Although scanning laser ophthalmoscopy has dramatically improved 
angiography, the instrument is very expensive and a skilled and experienced user is needed to 
obtain high quality angiograms.  Media opacities also limit the quality of the images36.   
 
1.3.3 Retinal vessel analyzer 
This instrument assesses change in diameter (relative units) but is not capable of measuring 
blood velocity or flow. An image of the fundus is displayed on a monitor for real time 
inspection. A region of interest is defined by the examiner and the diameter of the vessel 
(arteriole, venule, or both) inside this region is determined using an algorithm that detects the 
vessel edges at a maximum frequency of 50Hz37. Change in vessel diameter is expressed as a 
function of time or relative position along a vessel38.  
 
1.3.4 Color Doppler Imaging 
Color Doppler imaging (CDI) was first technique used to image blood flow in the heart and large 
vessels such as carotid artery39.  At the present time it is also used in ophthalmology mostly to 
measure blood velocity in the ophthalmic artery, central retinal artery, and posterior ciliary 
arteries which are all located immediately behind the globe and supply the eye40. Doppler shift is 
the change in frequency of the sound wave when it reflects off a moving object (in this case red 
blood cells).  This shift is directly proportional to the magnitude of the velocity.  The Doppler 









where ΔF is the Doppler shift, f0 is the frequency of the ultrasound beam, Vblood is the velocity of 
the red blood cells creating the Doppler shift, Vsound is the velocity of the ultrasound through the 
body, and θ is the angle between the incident beam and the direction of movement of the red 
blood cells21.   
 
The strength of the CDI is its ability to image patients with poor ocular media as it uses sound 
waves rather than laser.  A clear view of the fundus is not required; therefore pupil dilation is not 
necessary.  One of the limitations of this technique is that it requires an experienced technician to 
get reproducible data; variation of the angle Ө will result in large differences of blood velocity.  
Also if the probe is pushed strongly against the eyeball it can change the IOP and in turn the 
velocities being measured.  This device cannot quantify flow as it does not measure vessel 
diameter and it is a very expensive technology. 
 
1.3.5 Laser Based Instruments 
Laser has been used as a surgical treatment tool since 196041.  Two properties of the laser make 
it suitable to be used in the clinical settings for surgical purposes; its high intensity and low beam 
divergence.  Recently, another two properties of the laser are used to develop diagnostic tools, 
that is the monochromaticity and coherence of the emitted light.   
 
1.3.5.1 Laser Doppler Flowmetry 
The laser Doppler flowmeter (LDF) is a laser Doppler device which examines the volumetric 
flow in the capillary beds of the retinal tissue and not in large vessels.  Petrig and colleagues42 
showed that flow measurements could not distinguish between choroidal and retinal sources of 
Doppler shifts.  Therefore, LDF is only used to measure subfoveal choroidal blood flow and 
optic nerve head microcirculation2;41.     
 
The laser is focused onto a 50 μm diameter circular area of the fundus and then the scattered 
light is collected by a photodetecter from a larger circular area (150 μm) of the fundus 
surrounding the laser spot2;41.  By collecting the scattered light from a larger area surrounding the 
incident beam, laser light can scatter deeply into the tissue being measured.  The interference 
pattern between the Doppler shifted and non Doppler shifted frequencies are then analyzed by 
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LDF to derive localized volumetric blood flow measurements.  LDF is limited to the assessment 
of certain sites as described above and blood flow values are in arbitrary units which have poor 
reproducibility2;43.     
 
The Heidelberg Retina Flowmeter (HRF, Heidelberg Engineering, Germany) is a confocal 
scanning version of the LDF.  Using this technique, the HRF laser repeatedly sweeps the fundus.  
HRF measurements tend to be concentrated on surface vasculature because it only analyzes the 
scattered light from the illumination point which prevents the laser from penetrating deep in the 
tissue2. Work from our laboratory has shown that artificially induced light scatter erroneously 
elevates HRF values44. 
   
1.3.5.2 Laser Doppler Velocimetry 
Bidirectional laser Doppler velocimetry (LDV) is a technique used to measure the maximum red 
blood cell velocity in the large retinal vessels21;45.  In the bidirectional technique, one incident 
beam is used to illuminate a site along a retinal vessel.  The light scattered by the blood cells at 
the illuminated site is detected simultaneously by two distinct detectors separated from one 
another by a fixed known angle41 (Figure 1—1). Maximum velocity of the red blood cells are 
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Figure 1—1. Bidirectional laser Doppler Velocimetry. 
Vmax is then used to derive Vmean.  In a turbulent flow system, Vmin=Vmax, however, in most 
situations a laminar flow is assumed such that, Vmean= ½ Vmax.  Other prominent researchers in 
the field utilized a factor of 1.6 to derive Vmean from Vmax (i.e. Vmean = Vmax/1.6)7;45;46, however, 
Vmean= ½ Vmax. is now generally accepted to described the relationship of these two factors, at 
least in relatively straight vessel segments of minimum diameter 50um and distant from 
bifurcations. Average volumetric flow can also be computed if the corresponding vessel diameter 
(D) is measured45:  
 
Blood Flow = ½ (π.D2/4) Vmean.60 
 
This calculation assumes that the vessel has a circular cross section which is not always the case 
but the errors introduced by this assumption are very small47.  
 
Early instruments developed by Riva et al.48 and Feke et al.49 comprised a fundus camera or slit 
lamp, respectively, to which a laser and photodetectors were attached for the assessment of 
retinal hemodynamics. These early instruments, based on the concept of the bidirectional LDV, 
were difficult to use for anyone other than their developers.  One difficulty was getting centerline 
blood velocity measurements despite the subjects’ eye movements which would put the incident 
beam off the vessel center or off the vessel completely41.   
 
1.3.5.3 Canon Laser Blood Flowmeter 
The Canon Laser Blood Flowmeter (CLBF) utilizes new technology to overcome the problems 
of the bidirectional LDV mentioned above. In order to lock the laser beam on the center of the 
vessel despite minor eye movements, Feke et al.50 developed an eye tracking mechanism. Eye 
tracking is achieved by projecting a stripe shape from a green HeNe laser (544 nm, 1500x150 
µm rectangular) through a beam steering galvanometer system onto the retinal vessel of interest.  
The green laser is manually manipulated by the operator in order to be oriented perpendicular to 
the vessel segment being measured.  The image of the vessel and superimposed stripe is incident 
on an array sensor which detects any lateral motion of the vessel, and controls the steering 
system to stabilize the center of the green tracking stripe on the center of the vessel.  The beam 
from a red diode laser (675nm, 80x50 µm oval) is the laser Doppler measuring source.  The 
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beam is centered on the green stripe so that it also is stabilized on the target vessel41. The red 
laser is used to measure velocity every 0.02 seconds across a 2 second measurement window 
resulting in a velocity-time trace. The retinal vessel diameter is also measured using a 
densitometry technique from the signal produced by the image of the vessel on the array sensor. 
Diameter readings are acquired every 0.04 seconds during the first and final 60 milliseconds of 
the 2 second velocity measurement window. Two sequential measurements (path 1 and path 2) 
both of blood velocity and of vessel diameter are taken to ensure consistency of each parameter 
and are then averaged to give one reading. 
 
The axial length of the eye needs to be input in the instrument and ocular refractive error is 
automatically measured by the instrument itself.  Magnification effects associated with refractive 
and axial components of ametropia are corrected to provide absolute measurements of diameter 
(μm), velocity (mm/sec) and flow (μL/min). 
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Figure 1—2. Top Left: CLBF model 100, top right: operator's
view showing the green laser locked on a branch of retinal
vessel, bottom half: measurement window showing blood
velocity curves and densitometry profile of the vessel diameter. 
 
One of the many advantages of the CLBF is the simultaneous measurement of the blood velocity 
and vessel diameter in only 2 seconds.  Furthermore, CLBF is currently the only instrument that 
provides us with absolute measurements of the retinal blood flow rate in μl/min2;21;41;45. One 
limitation is the difficulty of obtaining results from patients with poor optics.   
A recent study showed a strong correlation between both volumetric blood flow and velocities 
found by the CLBF, and central retinal artery blood velocities found by Color Doppler 
Imaging51. The CLBF has been extensively evaluated in clinically normal subjects and those 
with various types of retinal diseases10;52;53. Multiple studies have shown good repeatability and 
reproducibility of the CLBF measurements with low variability10;54;55. Therefore, the CLBF can 
be used for reliable comparison of blood flow characteristics at different retinal vascular sites in 




Except for the most developed countries where surgical  correction is widely available, cataract 
is the leading cause of blindness worldwide56. The prevalence and incidence of cataract increases 
with increase in age 57. 
 
1.4.1 Optical Changes 
Light entering the eye can be scattered by optical imperfections.  This scattering is subdivided 
into light scattered towards the retina (forward scatter) and light scattered backwards towards the 
source (backscatter).  Back scattered light is usually not equal to forward light scatter and one 
cannot be directly deduced from the other58.  The healthy human lens light scatter is less than 
5%, and the contribution from the lens is approximately 50% of the total scattering in the eye59.  
Different parts of the lens have different scattering characteristics60.  Both loss of light energy 
due to absorption and the scattering of light reduce the contrast of the retinal image.  Forward 
light scatter is responsible for the reduction of the retinal contrast and therefore the assessment of 
forward light scatter is a more valid reflection of visual performance in glare conditions than 
backward scatter. 
 
According to the scatter theory and studies on excised lenses, light scattering in the lens is 
wavelength dependent59;60; however, this is contradictory to many of the psychophysical 
measurements59. Light scatter in donor lenses increases monotonically from 700nm towards 
400nm59;60; therefore, there is a greater degree of scatter for shorter wavelength light. This 
wavelength dependency varies by age and is greater in older subjects60. 
 
Various studies have documented increase in the ocular light scatter as a function of age using 
different methods58;61;62.  Lens light scatter and transmission indices both change gradually until 
middle age and then a rapid change follows later in life with increase in the variability between 
subjects.  Except for the lens, other refractive components of the eye (e.g. cornea) show little or 
no age-dependent change in the transmittance of light63.   
 
Since the lens does not shed any of its cells, all the cellular components from embryonic 
development onward are retained. The older cells of the lens, which are displaced toward the 
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center, experience progressive compaction, reduced metabolic activity and ageing. The lens 
becomes increasingly coloured (yellow) with age, more so in people with diabetes due to 
increased glycation, and the intrinsic fluorescence also increases, thereby increasing the 
absorbance of blue light64-66.   
 
In summary, throughout life lens transparency decreases causing increase in the intraocular light 
scatter and decrease in the spectral transmittance. These changes are more severe in the 
cataractous lenses causing more dramatic visual problems than mere ageing. The yellowing of 
the lens impacts color perception.  Changes in the refractive error are also common in cataract, in 
particular increasing myopia and astigmatism.  These refractive changes can be corrected with 
spectacles.  However, changes in the structure of the lens may result in pockets of lens material 
with different refractive indices, which cannot be corrected adequately with spectacles67;68.   
 
1.4.2 Common Types of Cataract 
There are three main morphological types of cataract: nuclear, cortical, and posterior 
subcapsular.  Nuclear cataracts result from excessive nuclear sclerosis and yellowing, with 
consequent formation of a central lenticular opacity. In some instances, the nucleus can become 
very opaque and brown, termed a brunescent nuclear cataract.  
 
Changes in the ionic composition of the lens cortex and the eventual change in hydration of the 
lens fibers produce a cortical cataract.  Cortical cataracts are wedge-shaped opacities in the lens 
periphery which progress toward the center.  Vision is not affected until these spokes intrude the 
pupil area67;68.   
 
Posterior subcapsular cataracts form when abnormal epithelial cells and extracellular granular 
and fibrillary material aggregate in the posterior subcapsular cortex and make plaque like 
opacities67-69. Even mild posterior subcapsular cataracts can drastically impact vision as these 
opacities are located in the center of the pupil area.  
Pure forms of cataract, with only one type of opacity present, are usually found in the early 
stages of the disease, but as it becomes more severe, several types of opacity often co-exist in the 




Among 100,000 births, 30 infants are born with congenital cataract either in isolation or as part 
of a more complex syndrome71. Approximately 30% of these cases are hereditary with the 
majority involving autosomal dominant genes, although autosomal recessive and X-linked forms 
are also known72. Responsible genes may also play a role in some cases of age-related cataract73.   
   
1.4.3.2 Genetic Factors 
In two separate studies, extracted human lens epithelial cells of cataract patients revealed down 
regulation of 262 to 412 genes and up regulation of 7 to 919 genes compared with cells from 
normal lenses74;75. All these data suggest a multi-factorial nature of the age-related cataract and 
the complexity of the genetic factors involved72.     
 
1.4.3.3 Age 
Ageing causes changes in the structural, optical, and molecular characteristics of the lens which 
in turn increases the intraocular light scatter, leading to slow but steady development of cataract 
throughout life. However, some of these changes are accelerated in the cataractous lenses 
compared with age matched normal lenses. For example, formation of high-molecular weight 
protein aggregates accompanies ageing, but the process is greatly accelerated in cataract 
development70.   
 
1.4.3.4 Environmental Factors 
The UV range of wavelengths in sunlight are the most significant environmental factor 
contributing to the development of cataract in humans76. Although most studies have emphasized 
the risks of UVB in cataract development, both UVA (320-400nm) and UVB (290-320nm) are 
thought to play significant roles in human cataract77. Exposing rats to UVA plus UVB has shown 




Reduced levels of glutathione is evident in most forms of cataract which might indicate a loss of 
the ability of the lens to withstand oxidative stress or that the protective mechanisms have been 
overcome1;70. One of the damages of the oxidation to the lens is modification of its protein 
structures. There is a little protein oxidation observed in the young lenses and only relatively 
minor oxidative changes are seen in the proteins of older clear lenses. In cataractous lenses, 
however, extensive oxidative modification of proteins is evident. Lenses incubated in the 
presence of hydrogen peroxide certainly demonstrate electrolyte imbalance, increased 
permeability, and reduced transport ability by oxidation1. Smoking is strongly associated with 
nuclear cataract using a variety of study designs79-81.  Smokers seem to have lower ability to cope 
with oxidative stress in general, and several constituents of cigarette smoke are capable of 
causing chemical modification of lens proteins70.    
 
1.4.3.6 Metabolic Disorders 
Electrolyte balance and consequently normal hydration of lens fiber cells are extremely 
important for maintaining the transparency of the lens. Therefore, metabolic disorders such as 
diabetes mellitus, and renal failure could potentially lead to lens opacification. For instance, risk 
of developing cataract is 12 times higher in patients with renal failure which may be due to 
accumulation of urea leading to carbamylation of lens proteins82. Cataract can develop rapidly in 
uncontrolled diabetes mellitus1;83;84. Hypoglycemia in newborn infants is known to cause cataract 
due to inability of the lens to produce sufficient metabolic energy1.  
1.4.3.7 Trauma 
The lens becomes white soon after the entry of a foreign body, since interruption of the lens 
capsule allows aqueous and sometimes vitreous to penetrate into the lens structure1. Electric 
shock is another rare cause82.   
 
1.4.3.8 Drug­Induced Changes 
Corticosteroids administered over a long period of time, either systemically or topically, can 
cause lens opacities. Other drugs associated with cataract include phenothiazines, amiodarone, 





Use of antioxidants such as vitamins A, C and E is suggested as a preventive method to minimize 
oxidative damage to the lens85.  Other pharmaceutical interventions such as Beta-Carotin and 
alpha-tocopherol are also tested as ‘anticataract’ drugs86. However, no drug or nutritional 
supplement to date has shown any significant result to reduce cataract or stop its progression in 
human. Some ‘anticataracts’ have lead to side effects and yet others have not proven efficient 
and successful. Therefore, use of any antioxidants or nutritional supplements has very little 
impact, if any, on cataract development and progression87. 
     
1.4.4.2 Surgical Management 
Surgical removal of the cataractous lens and replacing it with an intraocular lens has been the 
single most effective treatment of cataract and it is now more efficient than ever before. With the 
use of phacoemulsification procedure, cataractous lens can be extracted through a 3mm limbal 
incision under local anesthesia. Intraocular lens is folded and put in place through the same 
opening. The smaller incision means fewer complications including collapse of the contents of 
the eye during surgery and suture-induced astigmatism88. Cataract surgery is very successful as 
documented in numerous studies showing improved visual functions. According to one study by 
Rubin et al. 89, following surgery, most patients' scores on visual acuity, contrast sensitivity and 
glare disability returned to normal. They also claim that patients were equally likely to regain 
normal visual function after surgery regardless of their preoperative vision. Patients also 
experience better color perception after cataract surgery and better quality of life. The most 
common post operative complication of cataract surgery is posterior capsule opacification 
(PCO), which occurs in about 25% of the cases, usually 5 years after the surgery. It is most 
commonly treated by laser capsulotomy (Nd-YAG; wavelength 1064nm) in the clinic while 
patient is sitting upright and fixating on a target. The goal of laser capsulotomy is to open a hole 
in the posterior capsule, allowing improved clarity of the visual axis and therefore better vision88. 





It is very important to be able to classify and grade lens opacities for clinical use and also for 
epidemiological studies trying to find underlying causes of cataract. It is not only important to 
consider the location of the lens opacity but also to document its intensity and size. Various 
classification systems exist; some assess the morphology of the lens using the slit-lamp (LOCS, 
OCCCGS) and some assess the change in visual function.  
 
1.4.5.1 LOCS III 
The Lens Opacities Classification System III (LOCS III) photographic set consists of six slit-
lamp images for grading nuclear color and nuclear opalescence, five retro illumination images 
for grading cortical cataract, and five retro illumination images for grading posterior subcapsular 
cataract. Cataract severity is graded on a decimal scale, and the standards have regularly spaced 
intervals on a decimal scale90. With 0.1-unit intervals, nuclear color and nuclear opalescence 
scores summarize the nuclear color or opacity of the lens in one numeric dimension between 0.1 
(colorless or clear) to 6.9 (brunescent or very opaque). In cases of cortical and posterior 
subcapsular cataract, the scale ranges from 0.1 to 5.9 91. LOCS III has great reproducibility with 
95% tolerance limits of 0.4 to 1.090.  
1.4.5.2 OCCCGS 
The Oxford Clinical Cataract Classification and Grading System (OCCCGS) is another 
composite slit-lamp based system that employs standard diagrams and Munsell colour samples to 
grade specified features in different anatomical zones in the lens67;68;92. Sparrow and colleagues93 
developed a decimal version of the Oxford system with finer scale intervals, which substantially 
improved its reliability due to higher levels of repeatability and scale sensitivity. 
 
1.4.5.3 Visual Acuity and Contrast Sensitivity 
LogMAR visual acuity (VA) and contrast sensitivity (CS) scores are associated with the severity 
of some types of cataract94;95. Nuclear cataract impacts VA and CS the most and cortical 
opacities the least94. 
 
VA is widely used in clinical settings for visual assessment of patients with cataract. However, it 
is not an adequate assessment of vision in these patients as some have relatively good VA but 
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suffer from poor dynamic visual performance. CS is suggested by some researchers to be an 
important test along with VA for assessing cataract patients89.  
 
As seen in the following graph, both patients with refractive error and increased light scatter 
have approximately the same high contrast VA but the later one is more likely to have poorer 
vision in everyday life. Pelli-Robson CS or low contrast VA tests would be better to assess visual 
function in this case. The Pelli-Robson chart consists of rows of letters of the same size but 
decreasing contrast which gives an indication of CS just below the peak of the CSF curve (0.5-2 
c/d)67;68.   
  
Figure 1—3. (a) contrast sensitivity function (CSF), (b) comparison of CSF for 
normal, refractive error and increased light scatter68. (Image reproduced by permission 
of OT, the magazine of the Association of Optometrists, www.optometry.co.uk) 
Small letter CS test (high spatial frequency) is thought to be more sensitive to early cataractous 
change than both large letter CS (low spatial frequency) and VA96. Furthermore, large letter CS 
is more relevant in the assessment of patients in the later stages of cataract development as they 
hardly see any of the small letters89;96;97.  High correlation between VA and high spatial 
frequency CS (r2 = 0.70) makes it less likely to be used in clinical settings in addition to VA96. 
Other studies have also shown that CS provides little information beyond VA in visual 
assessment of patients with cataract94;98;99.   
 
1.4.5.4 Brightness Acuity Tester 
Forward light scatter is one of the characteristics of cataract that causes reduced contrast of 
image on the retina. Forward light scatter becomes more problematic when the light level differs 
largely in different parts of the visual field (e.g. when the sun is low in the sky or when viewing 
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oncoming car headlights at night). This phenomenon is known as disability glare67;68;100. The 
Brightness Acuity Tester (BAT) provides measurements of functional visual acuity under three 
different lighting levels which mimic everyday lighting conditions. It consists of an internally 
illuminated hemispherical bowl with a hole in the middle. It is a handheld instrument that patient 
holds and looks at the chart through the opening. This provides a bright uniform glare source that 
can be used in conjunction with VA and CS tests.   
 
1.4.5.5 Potential Acuity Meter 
The Potential Acuity Meter (PAM) is a test for assessing retinal function in patients with 
cataract. The PAM uses a single channel Maxwellian view projection system to image a letter 
chart onto the patient's retina. The Maxwellian view arrangement ensures that the light source is 
imaged in the plane of the patient's entrance pupil thereby ensuring that a very narrow beam of 
light passes through the lens67;68. The examiner minimizes the effects of the cataract by selecting 
a relatively clear portion of the lens. Several factors such as visual acuity of 20/200 or worse, the 




Van den Berg developed an idea originally proposed by Le Grand (1937) to directly measure the 
light scatter function of the human eye2;67;68. The Straylight Meter is a device that measures 
intraocular stray light by using the psychophysical direct compensation approach100;102.   
 
Vision in elderly can be affected by increase in lens opacity and also by neuronal degradation of 
retina (i.e. photoreceptor loss, and/or axonal loss in the optic nerve). Visual acuity and contrast 
sensitivity tests are influenced by loss of neuronal function as well as lens opacity.  Measuring 
Forward light scatter has the advantage of being relatively free from neuronal interactions103. 
Several studies have shown that forward light scatter is a better, more sensitive predictor of 





There are several commercially available cameras that use Scheimpflug principle and are capable 
to image the entire anterior segment of the eye in vivo. This will allow researchers and clinicians 
to document 3-D arrangements of the lens opacities and evaluate intraocular light scatter 
conditions. Image analysis is based on peak height and distance evaluation of 2 layers in the 
cornea and 10 layers in the lens105. The Scheimpflug principle requires that the plane containing 
the slit beam and the image plane intersect at one point, with the corresponding angles equal106.   
 
1.5 Simulated Light Scatter Model  
An artificial light scatter model has been used in various studies to induce light scatter. The 
impact of simulated light scatter has been studied on the outcome of clinical automated 
perimetry107-109, digital retinal imaging110, HRF44, and HRT111. 
 
Suspension of varying concentrations of 0.5μm polystyrene microspheres could be used to create 
light scatter that increases as more concentrated suspensions are used. These solutions can be 
injected in a cell apparatus made up of two plano lenses enclosed in a plastic collar, which can be 
placed close to the subjects’ eyes to create light scatter. A bead diameter of 0.5μm was selected 
as the diameter of the protein aggregates in human cataractous lenses is shown to be between 300 
and 500 nm112. 
 
1.6 Summary 
Ocular circulation, blood flow and various hemodynamic assessment techniques were reviewed 
here. One of the laser based instruments reviewed is the CLBF, used extensively in our lab and 
elsewhere to investigate the physiology of retinal hemodynamics17;113;114 and the 
pathophysiology of hemodynamic disturbance in diseased states such as diabetes113;115;116.  
 
Cataract was also addressed in this introduction. There are many ways to grade cataract and 
quantify the amount of intraocular light scatter produced by cataract, which were discussed here. 
A simulated light scatter model has also been developed to study the impact of light scatter on 
different instruments which mimics the impact of cataract. The impact of light scatter due to 
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cataract on the outcome of retinal hemodynamic assessment techniques, such as that used in the 





























The eye is regarded as a window to the human body providing us with a unique opportunity to 
use non-invasive methods and to directly visualize the retinal vasculature. The retinal circulation 
has been studied in normal and diseased states and hemodynamic disturbances have been 
documented in some ocular diseases. Assessment of retinal hemodynamics enables us to study 
the pathophysiology of the disease, and might in the future allow us to monitor its progression 
and response to various treatment modalities, and perhaps in the near future assist us in early 
detection of not only the ocular diseases but also other systemic illnesses with ocular 
manifestations.  
 
The CLBF is a novel instrument used to assess retinal hemodynamics; it measures blood vessel 
diameter and velocity and calculates the blood flow, all in real units. There are other instruments 
using similar algorithms to measure vessel diameter and yet others that use different techniques 
to assess retinal blood flow. Some of these instruments including the CLBF are impacted by the 
intraocular light scatter as they rely on the clear media allowing light to pass to the retina and 
return to the detectors with minimal interference from the lenticular opacity. The impact of light 
scatter on the CLBF has never been studied despite its wide use in the elderly population where 
increase in the intraocular light scatter is always observed and concomitant cataract is almost 
inevitable. 
 
The overall aim of this project was to investigate the impact of light scatter on the retinal 
hemodynamic measurements and to investigate ways to minimize this impact. In the first study, 
young healthy subjects were recruited and light scatter was induced using the artificial light 
scatter model developed by Hudson et al110. Induced light scatter was increased by using more 
concentrated solutions in the lens apparatus that was placed in front of the CLBF and serial 
measurements were acquired from the same vessel segment on a retinal arteriole. Our hypothesis 
was that the induced light scatter would impact the CLBF measurements. In the second study, we 
further studied this impact by imaging real patients undergoing cataract surgery. Several 
measurements of the same spot on a retinal arteriole were acquired using the CLBF, before and 
after the surgery. Our hypothesis was that measurements acquired before (i.e. opaque media) and 
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after the surgery (i.e. clear media) would follow the same trends we found with the artificial light 
scatter model. 
 
The findings of this project would not be limited to the CLBF as there are many other 
instruments using similar algorithms. These instruments are widely used to investigate the 
disease processes in elderly population often over a period of time where not only the 
concomitant cataract can impact the results but also an increase in intraocular light scatter over 
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The potential of non-invasive retinal imaging techniques to investigate the physiological 
mechanisms regulating blood hemodynamics in the human retina have long been recognized.  
However, techniques are now available that permit the non-invasive quantification of volumetric 
retinal blood flow in absolute units by simultaneously measuring vessel diameter (μm) and 
centerline blood velocity (mm/sec) to derive flow in real units (μl/min)10;53;55. Blood flow 
assessments using the Canon Laser Blood Flowmeter (CLBF) are repeatable and reproducible 
with low variability2;11;21.   
 
Disturbance of retinal blood flow is a feature of many ocular diseases1;117, including diabetic 
retinopathy1;11;22;35;117, age-related maculopathy28, and a subset of patients with glaucoma21;27.  In 
the future, the assessment of retinal blood flow may play a diagnostic role in the early detection 
of some of these ocular diseases22.  Retinal hemodynamic assessment techniques may also be 
used to monitor aspects of disease progression and to evaluate the retinal vascular response to 
surgical and drug treatments21.   
 
Lens opacity, or cataract, frequently occurs concomitantly with other eye diseases, including 
diabetic retinopathy, age-related maculopathy and glaucoma.  The impact of lens opacity on the 
assessment of retinal blood flow is unknown, despite the fact that the technique has been used 
widely in elderly subjects.  The clarity of fundus visualization using any fundus camera based 
imaging device is limited in the presence of lens opacity due to intraocular light scatter that 
results in reduced image contrast.  Recent studies from our group have quantified the influence 
of artificial light scatter on various retinal imaging instruments44;110;111. The present study was 
designed to determine the impact of artificial light scatter on quantitative measurements of 







One eye from each of 10 healthy young subjects between the ages of 18 and 30 (mean age 23.6 
years, SD 3.4) was randomly selected. All volunteers were informed about the details of the 
study and gave their consent to participate.  The research followed the tenets of the Declaration 
of Helsinki and was approved by the Research Ethics Board of the University Health Network 
and also by the Office of Research Ethics of the University of Waterloo. All subjects were drug 
free with no systemic disease, no ocular abnormalities and no history of any ocular surgery.  
Subjects had no lens opacity, exhibited intra-ocular pressures less than 21 mmHg, a logMAR 
visual acuity of 0.0, or better, and a refractive error < ±6.00 DS and < ±2.50 DC. 
  
Artificial Light Scatter Model 
The details of the artificial light scatter model have been published elsewhere44;110;111. In brief, 
cells comprising a plastic collar and two plano lenses were filled with solutions of differing 
concentrations of polystyrene microspheres110 (Polybead© Polysciences Inc., USA).  The 
diameter of the microspheres was chosen to be similar to the mean diameter of aggregated lens 
proteins (500nm) that are thought to produce intraocular light scatter in the normal ageing lens.  
Microsphere concentrations of 0.002%, 0.004%, 0.006%, and 0.008% were made up from a 
0.16% stock solution and a distilled water only cell was also utilized to act as a further control 
i.e. anticipated not be different from baseline. The microsphere concentrations were determined 
empirically prior to commencing the study by imaging subjects using the CLBF and determining 
the point at which the instrument could no longer reliably stabilize a given measurement site. 
Solutions were made-up and the cells were emptied, cleaned and refilled every week. Cells were 
also checked regularly with a spectrophotometer to ensure consistency of the optical 
transmission and absorption characteristics throughout the course of the study. 
 
Quantitative Assessment of Retinal Arteriolar Blood Flow  
Quantitative Assessment of retinal arteriolar blood flow were acquired using the Canon Laser 
Blood Flowmeter (CLBF), model 100. The CLBF utilizes bidirectional laser Doppler 
velocimetry (LDV) to quantify the centerline blood velocity in the large retinal vessels, 
densitometry to measure vessel diameter and an image stabilization system to minimize the 
impact of eye movement21;45.  A red diode laser (675nm, 80μm x 50 μm oval) is used to acquire 
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bi-directional LDV measurements.  The frequency shift of the light scattered by the moving 
blood cells at the illuminated site is simultaneously focused by two distinct photodetectors 
separated from each other by a fixed, known angle41.  The maximum frequency shift detected by 
each photo-detector is subtracted to allow the absolute quantification of centerline blood 
velocity, irrespective of the angle between the moving particle and reflected beam49;118.  The 
resulting Doppler signal is analyzed using a previously described algorithm49. The frequency 
shift is determined as the frequency at which there is an abrupt reduction in the amplitude of the 
fluctuations in the Doppler-shift power spectrum. This determination does not depend on any 
presumed shape of the average power spectral density curve. Velocity measurements are 
acquired automatically every 0.02secs throughout the 2secs measurement window, resulting in a 
velocity-time trace that depicts the systolic-diastolic variation of blood velocity.   
 
Retinal vessel diameter is determined by projecting a rectangular (1500 μm x 150 μm) green 
(543 nm) HeNe diode laser perpendicular to the vessel segment measurement site. Densitometry 
analysis of the cross-sectional vessel image on the CLBF array sensor is used to calculate vessel 
diameter (Figure 3—1).  The minimum point (Min1) in the central portion of the image is 
designated as the nominal vessel center with D1 being its signal level from the background level.  
When mirror reflection occurs from the vessel wall, the second minimum point is observed in the 
neighborhood of Min1 with signal level D2.  The maximum points on either side are detected as 
the vessel edges with D3 and D4 signal levels. The half height points (X1 and X2) are points on 
the image whose signal levels are (D1+D3)/2 and (D2+D4)/2, respectively. The width between X1 
and X2 is taken to represent the uncorrected vessel diameter and is converted into micron units 
after correction for axial and refractive magnification effects45;119. Diameter measurements are 
acquired every 4msecs during the first and last 60msecs of the 2 second velocity acquisition 
window.   
 
An integral “eye tracking” mechanism stabilizes the laser system on the selected measurement 
site. Light from the red laser is projected into the center of the green rectangle41. The green laser 
is manually adjusted perpendicular to the vessel segment.  The resulting cross-sectional image of 
the vessel is focused on the CLBF array sensor. The array sensor detects any lateral motion of 
the vessel and, via a negative feedback loop, controls the galvanometer steering system to 
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stabilize the green tracking laser on the selected measurement site. This system also permits 
identification, and post-acquisition rejection, of velocity measurements impacted by significant 
saccades. 
 
Two sequential measurements (Path 1 and Path 2) both of blood velocity and of vessel diameter 
are taken to ensure consistency of each parameter and are then averaged to give one reading.  
Vmean, the time average of the centerline blood velocity, is used along with the diameter, D, to 
calculate retinal blood flow, F, assuming that the vessel has a circular cross section and that the 
flow characteristics obey Poiseuille’s law.  Retinal blood flow is derived using the formula: F = 
½ (π . D2/4) (Vmean . 60), where flow is in μl/min, diameter is in μm and Vmean is in mm/sec. 
Magnification effects associated with refractive and axial components of ametropia are corrected 
to provide absolute measurements of diameter (μm), velocity (mm/sec) and flow (μL/min).  
 
 
Figure 3—1  Densitometry signal of a cross-sectional image acquired from a retinal arteriole. 
Min1; minimum point in the central portion of the image designated as the nominal vessel center. 
D1; signal level of Min1 from the background level. D2; signal level of the second minimum point 
in the neighborhood of Min1.  D3 and D4; signal levels of the maximum points on either side 
designated as the vessel edges.  X1 and X2; the half height points whose signal levels are 
(D1+D3)/2 and (D2+D4)/2, respectively. The width between X1 and X2 is taken to represent the 
uncorrected vessel diameter. (Image courtesy of Canon Inc, Japan) 
 
Procedures 
Each subject underwent screening that included the assessment of general and ocular health, best 
corrected logMAR visual acuity, anterior segment examination, assessment of crystalline lens 
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status (using the Lens Opacity Classification System, LOCS, III) and fundus examination.  The 
randomly selected study eye was dilated using Mydriacyl 1% (Alcon Canada Inc. Mississauga, 
Canada). Retinal arteriolar hemodynamics were then measured in a superior temporal arteriole. 
The measurement site was selected in a relatively straight vessel segment, distant from any 
bifurcations and within 1 disc diameter of the optic nerve head. Initial measurements were 
acquired with no cell in place as a baseline to optimize and set the instrument focus and 
positioning.  Retinal hemodynamics measurements were then acquired at the same measurement 
site (using the fixation target memory feature of the CLBF) while placing cells of various 
microsphere concentrations in front of the subjects’ eye in random order. The randomization was 
implemented in order to negate the impact of any potential drift of CLBF values or systematic 
change of hemodynamic parameters. The cells were mounted to the objective of the CLBF using 
a custom made adaptor that incorporated a 20° tilt to minimize surface reflections. Seven 
separate measurements were acquired with the CLBF for each light scatter condition, including 
the no cell situation. Background fundus illumination and room lighting were kept constant. 
Subjects were encouraged to blink before each measurement and, if necessary, artificial tears 
were used to avoid image degradation due to corneal tear film break-up. Laser intensity was 
maintained on low for all measurements. Axial length was measured using A-scan ultrasound (I3 
Innovative Imaging Inc, Sacramento, CA) to correct for magnification effects due to ametropia. 
These values were entered into the CLBF database prior to calculation of hemodynamic 
parameters. 
 
The CLBF allows the operator to use either low (standard) or high laser intensity. In order to 
investigate the impact of laser intensity on hemodynamic measurements, we also acquired retinal 
arteriolar hemodynamics both at low and at high intensity laser settings on four of the original 
ten subjects using the no cell condition (baseline) and the 0.006% and 0.008% microsphere 
concentration cells.  
 
Statistical Analysis 
Repeated measures Analysis of Variance (reANOVA) was used to determine the relationship, if 
any, between microsphere concentration and each of the hemodynamic parameters i.e. retinal 
arteriolar diameter, centerline blood velocity and blood flow.  For those situations in which a 
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significant effect was detected by the reANOVA, a Least Squares Difference post-hoc (LSD) 
comparison test was used to determine the magnitude of artificial light scatter concentration, 
relative to the no cell condition, that significantly impacted hemodynamic measurements. 
 
The high laser intensity results were compared to the standard laser intensity results for the 
baseline (i.e. no cell), 0.006% and 0.008% microsphere concentration cell conditions for the 
























3.3 Results     
Group mean (± standard deviation) retinal arteriolar diameter, centerline blood velocity and 
blood flow as a function of artificial light scatter condition are summarized in Table 3—1. 
Change of each of the retinal hemodynamic parameters relative to the baseline is shown in 
Figure 3—2.   
 
Group mean retinal arteriolar diameter and blood flow significantly increased (reANOVA, 
p<0.0001) with increase in microsphere concentration; however, centerline blood velocity was 
unaffected by artificial light scatter (reANOVA, p=0.4740).  The LSD post-hoc test revealed that 
the 0.006% and 0.008% microsphere concentrations produced significantly higher diameter and 
flow values than the baseline condition (i.e. no cell condition) (Figure 2).  Importantly, the water 
only cell condition produced almost identical values as the baseline for each of the 3 
hemodynamic parameters (Table 3—1).  The laser tracking system of the CLBF had difficulty 
stabilizing the laser on to the measurement site for the highest microsphere concentration; for 
this reason, it was impossible to acquire any measurements on 3 subjects using the 0.008% cell. 
 
Table 3—1.  Group mean (± standard deviation) retinal arteriolar diameter, centerline blood 

























































Figure 3—2  Change in retinal arteriolar 
diameter (upper), centerline blood 
velocity (middle) and blood flow (lower) 
relative to baseline for all cell 
conditions.  
The error bars represent ± 1 standard 
error of the mean (*; denotes significant 






















Table 2 and Figure 3 depict the hemodynamic assessment of 4 of the original 10 subjects using 
both high and low laser intensities. Diameter values attained using the high intensity laser were 
closer to the baseline; only the 0.008% concentration cell resulted in significantly greater 
diameter values than the baseline (p=0.0008). Diameter values were significantly less with the 
high intensity laser setting than the equivalent measurement with the low intensity laser 
(p=0.0007). Diameter values measured with 0.006% concentration cell were also significantly 
smaller when the high intensity laser was utilized (p=0.0306).  Centerline blood velocity was 
unaffected by laser intensity (p=0.2817).  Similarly, blood flow values attained using high 
intensity laser were closer to the baseline with only the highest light scatter condition being 
significantly greater than the baseline (p=0.0313) and were significantly less than the equivalent 
measurement with the low intensity laser (p=0.0221).   
 
 
Table 3—2. Group mean (± standard deviation) retinal arteriolar diameter, centerline blood 
velocity and flow as a function of artificial light scatter condition and laser intensity. 












































































Figure 3—3 Retinal arteriolar 
diameter (upper), centerline blood 
velocity (middle) and blood flow 
(lower) attained at the low (left) 
and high (right) intensity laser 
settings for the no cell, 0.006% 
and 0.008% microsphere 
concentrations.  
The error bars represent ± 1 
standard error of the mean (*; 
denotes significant difference from 
the baseline. The dashed line 
denotes a significant difference 
between identical cell conditions 








Our light scatter model resulted in an artifactual increase of retinal arteriolar diameter (p<0.0001) 
which in turn led to increased derived retinal blood flow values (p<0.0001).  The increase in 
blood flow was secondary to the induced change in arteriolar diameter since flow is directly 
proportional to the second power of diameter, according to the formula used by the CLBF. 
Centerline blood velocity, however, was not affected by light scatter.   
 
The densitometry technique that is used by the CLBF to measure vessel diameter is increasingly 
impacted as the magnitude of artificial light scatter increases (Figure 2). We hypothesize that as 
the light scatter increases, the densitometry image of the vessel looses contrast and the slopes of 
the densitometry profile broaden (Figure 4). This results in a greater separation of the half-height 
points causing an artifactual increase in the diameter of the vessel. Ultimately, light scatter will 
result in breakdown of the CLBF laser tracking system but artifactually increased vessel 
diameter values can be acquired prior to this point. On the other hand, it is clear that the 
bidirectional laser Doppler velocimetry technique used to measure centerline blood velocity is 
robust to the optical effects of artificial light scatter.   
      
Figure 3—4  Densitometry profiles of a vessel measured by the CLBF (left) and schematic 
representation (right). Upper: baseline (no cell condition). Lower: 0.006% microsphere 




It is apparent that the impact of light scatter upon the densitometric estimation of retinal vessel 
diameter can, in part, be negated by increasing the intensity of the HeNe laser (Figure 3). Future 
instrumentation could incorporate a negative feedback loop that automatically increases HeNe 
laser intensity in situations where the slope of the densitometry profile becomes shallow.  In 
addition, when assessing retinal blood flow in patients with concomitant cataract, we recommend 
using the high intensity laser setting of the CLBF.  CLBF parameters that do not rely on diameter 
estimation but still provide useful hemodynamic information, such as centerline blood velocity 
and maximum to minimum velocity ratio, should be given greater attention when assessing 
retinal blood flow in patients with concomitant cataract. 
 
The data precludes the possibility that a real change in diameter occurred. To explain, if the 
apparent increase in arteriolar diameter was real then this would be reflected by an increase in 
blood velocity (since vascular resistance would decrease). The magnitude of apparent increase in 
arteriolar diameter, if real, would be predicted to result in an increase of blood velocity. An 
increase in retinal arteriolar diameter of 3.2 ± 1.4 % following hypercapnic provocation resulted 
in an increase of blood velocity of 26.4 ± 7.0 %114. In effect, the finding of an increase in 
arteriolar diameter in the absence of an increase in blood velocity is contradictory and can only 
be explained as an artifact of the light scatter cells upon the densitometric estimation of vessel 
diameter. Furthermore, the magnitude of apparent increase in diameter for the 0.008% light 
scatter cell is outside the physiological range of diameter change produced by extreme 
hypercapnic and hyperoxic provocations17;114. 
 
Are the results of this study only relevant to the limited number of CLBF users worldwide and to 
those individuals with a specific interest in retinal hemodynamic assessment? A number of 
techniques designed to assess retinal vessel diameter, including the Retinal Vessel Analyzer37 
and the assessment of retinal photographs used in the Atherosclerosis Risk in Communities 
Study120, have been introduced. In particular, recent results from the Atherosclerosis Risk in 
Communities Study have found that retinal vascular abnormalities are predictive of 
cardiovascular disease121. However, both of these techniques37;120 use algorithms to assess retinal 
vessel diameter that are very similar to that used in the CLBF and therefore may be susceptible 
to artifact resulting from light scatter. Cataract is an inevitable consequence of aging and, 
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therefore, care needs to be exercised in the interpretation of studies of retinal vessel diameter that 
utilize cohorts with age as a co-variable. 
 
The results derived from any model, however, need to be interpreted with caution since the 
model may not accurately simulate the impact of true cataract. From a clinical perspective, we 
have previously demonstrated the impact of each artificial light scatter condition on fundus 
visualization achieved with a digital fundus camera that utilizes a polychromatic light 
source44;110. Direct comparison of our artificial light scatter model with a subjective, slit-lamp 
based cataract grading scale is difficult; however, the magnitude of light scattering medium used 
in this study is far less than that used to assess confocal optics based instrumentation44. 
Unpublished data from our lab demonstrates that the artificial light scatter model impacts visual 
acuity and letter contrast sensitivity in a very similar manner to that of nuclear sclerotic cataract.  
Future work will investigate the impact of light scatter induced by cataract on the retinal blood 
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Disturbance of retinal blood flow is a feature of many ocular diseases1;117, including diabetic 
retinopathy1;11;22;35;117, age-related maculopathy28, and a subset of patients with glaucoma21;27. 
Retinal hemodynamic assessment has the potential to play a role in the early detection and 
monitoring of some of these diseases22, as well as evaluating the retinal vascular response to 
surgical and drug treatments21. There are techniques available that permit the non-invasive 
quantification of retinal hemodynamics. One such instrument is Canon Laser Blood Flowmeter 
(CLBF) used to assess retinal blood flow in real units (μl/min), derived from simultaneously 
measuring vessel diameter (μm) and centerline blood velocity (mm/sec) 10;53;55. The impact of 
lens opacity on the assessment of retinal blood flow using the CLBF has never been studied, 
despite the fact that it has been used widely in elderly subjects where concomitant existence of 
cataract or intraocular light scatter is inevitable. 
 
Recent work from our group has shown that the densitometry technique that is used by a number 
of techniques to measure vessel diameter, including the CLBF, is increasingly impacted as the 
magnitude of artificial light scatter increases, resulting in artifactually elevated diameter and 
blood flow measurements122. The present study was designed to further investigate these findings 














Thirty patients scheduled for extracapsular cataract extraction using phacoemulsification and 
intraocular lens implantation were prospectively recruited. Ten patients met all the inclusion and 
exclusion criteria and were included in the analysis. Subjects were between the ages of 61 and 84 
years (mean age 73 years, SD 8). Subjects had no corneal abnormalities, including dry eye, 
scarring, dystrophy, and corneal transplant. Patients with post operative complications were 
excluded from the study. All volunteers were informed about the details of the study and gave 
their consent to participate.  The research followed the tenets of the Declaration of Helsinki and 
was approved by the Research Ethics Board of the University Health Network and also by the 
Office of Research Ethics of the University of Waterloo.  
 
Quantitative Assessment of Retinal Arteriolar Blood Flow  
The quantitative assessment of retinal blood flow was undertaken using the Canon Laser Blood 
Flowmeter (CLBF), model 100. The CLBF utilizes bidirectional laser Doppler velocimetry 
(LDV) to quantify the centerline blood velocity in the large retinal vessels (Figure 1), 
densitometry to measure vessel diameter (Figure 2) and an image stabilization system to 
minimize the impact of eye movement21;45.  The details of the CLBF have been published by our 
group 17;122 and numerous other groups41;45;49;55 previously. 
 
Velocity measurements are acquired automatically every 0.02secs throughout the 2secs 
measurement window, resulting in a velocity-time trace that depicts the systolic-diastolic 
variation of blood velocity.   
 
Diameter measurements are acquired every 4msecs during the first and last 60msecs of the 2 
second velocity acquisition window.   
 
Magnification effects associated with refractive and axial components of ametropia are corrected 












Figure 4—1   Bidirectional laser Doppler Velocimetry. A red diode laser (675nm, 80μm x 50 
μm oval) is used to acquire bi-directional LDV measurements.  The frequency shift of the light 
scattered by the moving blood cells at the illuminated site is simultaneously focused by two 
distinct photodetectors separated from each other by a fixed, known angle41.  The maximum 
frequency shift detected by each photo-detector is subtracted to allow the absolute quantification 
of centerline blood velocity, irrespective of the angle between the moving particle and reflected 
beam49;118.  The resulting Doppler signal is analyzed using a previously described algorithm49; 
the frequency shift is determined as the frequency at which there is an abrupt reduction in the 
amplitude of the fluctuations in the Doppler-shift power spectrum. This determination does not 












Figure 4—2   Retinal vessel diameter is determined by projecting a rectangular (1500 μm x 150 
μm) green (543 nm) HeNe diode laser perpendicular to the vessel segment measurement site. 
Densitometry analysis of the cross-sectional vessel image on the CLBF array sensor is used to 
calculate vessel diameter. The minimum point (Min1) in the central portion of the image is 
designated as the nominal vessel center with D1 being its signal level from the background level.  
When mirror reflection occurs from the vessel wall, the second minimum point is observed in the 
neighborhood of Min1 with signal level D2.  The maximum points on either side are detected as 
the vessel edges with D3 and D4 signal levels. The half height points (X1 and X2) are points on 
the image whose signal levels are (D1+D3)/2 and (D2+D4)/2, respectively. The width between X1 
and X2 is taken to represent the uncorrected vessel diameter and is converted into micron units 















Two visits were required to complete the study, one prior to the surgery and one at least six 
weeks after the surgery to allow for a level of post-operative recovery that would not hinder 
retinal imaging. The severity of cataract was documented using the Lens Opacity Classification 
System90 (LOCS, III) on the pre-operative  visit. Each subject underwent the assessment of 
intraocular light scatter status at both visits using logMAR ETDRS visual acuity charts (10% & 
90% contrast) and the Brightness Acuity Tester (BAT) at high and low illumination settings. The 
charts were illuminated to 100cdm-2 and the recommended viewing distance of 4 meters was 
employed. A “by-letter” scoring system was utilized that gave credit to each correct letter123. The 
order of chart presentation was randomized to minimize any familiarity that patients may gain of 
the letter composition of the charts. The eye to undergo surgery was dilated using Mydriacyl 1% 
(Alcon Canada Inc. Mississauga, Canada).  
 
Retinal arteriolar hemodynamics were measured in the superior temporal arteriole. The 
measurement site was selected in a relatively straight vessel segment, distant from any 
bifurcations and within 1 disc diameter of the optic nerve head. Retinal hemodynamic 
measurements were then acquired at the same measurement site post-operatively, with the aid of 
the fixation target memory feature of the CLBF. Seven to ten separate measurements were 
acquired with the CLBF at each visit. The CLBF allows the operator to use either low 
(standard) or high intensity HeNe laser. Based on our previous study122, the high laser intensity 
setting was utilized pre- and post-operatively to aid retinal visualization through cataract and to 
reduce impact of light scatter on the estimation of retinal vessel diameter. Background camera 
illumination and room lighting were kept constant between visits. Subjects were encouraged to 
blink before each measurement and, if necessary, artificial tears were used to avoid image 
degradation due to corneal tear film break-up. Axial length was measured using IOLMaster (Carl 
Zeiss Meditec) to correct for magnification effects due to ametropia. These values were entered 







The Wilcoxon signed-rank test was used to compare each of the hemodynamic parameters i.e. 
retinal arteriolar diameter, centerline blood velocity and blood flow, pre- and post-operatively, 
because the data was not normally distributed. All analyses were performed using SPSS 16.0.    
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4.3 Results 
Ten of the original thirty patients were included in the analysis. Twelve of the patients were 
impossible to image as the cataract was very dense and the laser tracking system of the CLBF 
had difficulty stabilizing the laser on to the measurement site, five were lost to follow up, two 
cancelled their surgeries, and one had inadequate post-op pupil dilation who were excluded from 
the study.  
 
Change in group mean retinal arteriolar diameter, centerline blood velocity and blood flow pre- 
and post-operatively are summarized in Table 1, while scatter plots showing the change of 
individual data post-operatively are shown in Figure 3. Group mean retinal arteriolar diameter 
and blood flow significantly decreased post-operatively (Wilcoxon, p=0.022 and p=0.028 
respectively). However, centerline blood velocity was unchanged (Wilcoxon, p=0.074) post-
operatively.  
 
Severity of cataract is recorded in Table 2, using the Lens Opacity Classification System (LOCS, 
III). Table 3 depicts changes in logMAR visual acuity as an assessment of intra-ocular light 
scatter (glare) achieved by subtracting the logMAR VA between high and low illumination 
settings on BAT. Both 10% and 96% contrast ETDRS charts were used. None of the differences 
were significant as the numbers were limited (n=9), and all the changes are positive as expected 
since there is more glare using high compared to low illumination. We expected to see a higher 
glare pre-operatively, which was the case using the 96% but not the 10% contrast chart 









Table 4—1  Group mean ± standard deviation (Median) retinal arteriolar diameter, centerline 
blood velocity and flow pre- and post-operatively (i.e. cataract and IOL, respectively) (IOL; 
intra-ocular lens). 
 Diameter [μm] Velocity [mm/s] Flow [μl/min] 
Cataract  
[n=10] 
120.54 ± 20.52 
(114.70) 
39.38 ± 8.26 
(38.16) 




106.23 ± 5.69 
(108.27) 
35.39 ± 9.00 
(37.02) 





Table 4—2  LOCS III system used to document the severity of cataract. Nuclear opalescence 
(NO), nuclear color (NC), cortical opacity (CO), post subcapsular (PS).  
LOCS III: NO NC CO PS
Mean  3.1 2.6 2.9 1.4




Table 4—3  Assessment of intra-ocular light scatter: Change in logMAR visual acuity between 
the high and low illumination settings of the Brightness Acuity Tester (BAT) using 10% and 
96% contrast ETDRS charts.  
∆ logMAR VA
10% 96%
Cataract  Mean  0.11 0.06 
SD 0.12 0.14




Figure 4—3  Boxplot (left) and Scatterplot (right) of each individual showing the retinal 
arteriolar diameter (upper), centerline blood velocity (middle), and blood flow (lower) measured 










Retinal arteriolar diameter was artifactually elevated in the presence of cataract (p<0.022) which 
in turn led to an increase of the derived retinal blood flow values (p<0.028).  The increase in 
blood flow was secondary to the induced change in arteriolar diameter since flow is directly 
proportional to the second power of diameter. Centerline blood velocity, however, was not 
significantly affected by light scatter produced by cataract.  These findings are in close 
agreement with those of our earlier study using simulated light scatter 122. 
  
The densitometry technique that is used by the CLBF to measure vessel diameter is impacted by 
the light scatter induced by cataract. In our previous publication, we hypothesized that as 
simulated light scatter increased, the densitometry image of the vessel lost contrast and the 
slopes of the densitometry profile broadened. Figure 4 illustrates this effect. Ultimately, light 
scatter will result in breakdown of the CLBF laser tracking system but artifactually increased 
vessel diameter values can be acquired prior to this point. On the other hand, it is clear that the 
bidirectional laser Doppler velocimetry technique used to measure centerline blood velocity is 
relatively robust to the optical effects of artificial light scatter, although the data does reveal a 
trend (Wilcoxon, p=0.074) for increased velocity in the presence of cataract.   
      
In our previous study122, we showed that using the high intensity laser setting of the CLBF 
reduced the impact of light scatter on the measured diameter values. Nevertheless, we have 
demonstrated in this study that using the high intensity laser setting of the CLBF still results in 
erroneous hemodynamic measurements in the presence of cataract. The use of the high laser 
setting was necessary in order to allow adequate visualization of the fundus and proper 
functioning of the laser tracking system of the CLBF. 
 
CLBF parameters that do not rely on diameter estimation may still provide useful hemodynamic 
information, such as centerline blood velocity and maximum-to-minimum velocity ratio, should 




The data precludes the possibility that a real change in diameter occurred following 
phacoemulcification and IOL implantation. To explain, if the apparent reduction in arteriolar 
diameter after surgical removal of the cataract was real then this would be reflected by a decrease 
in blood velocity (since vascular resistance would increase as a result of any true 
vasoconstriction). Furthermore, the magnitude of apparent change in diameter after surgical 
removal of cataract is outside the physiological range of diameter change produced by extreme 
hypercapnic and hyperoxic provocations 17;114. 
 
A number of techniques designed to assess retinal vessel diameter, including the Retinal Vessel 
Analyzer37 and the assessment of retinal photographs120, have been utilized. However, both of 
these techniques37;120 use algorithms to assess retinal vessel diameter that are very similar to that 
used in the CLBF and therefore may be susceptible to artifact resulting from light scatter. We 
showed significant change in retinal vessel diameter measurements of patients with mild to 
moderate cataract (Table 2). Cataract is an inevitable consequence of aging, therefore, care needs 
to be exercised in the interpretation of studies of retinal vessel diameter that utilize cohorts with 
age as a co-variable. 
 
Our analysis of intra-ocular light scatter using BAT and ETDRS charts (10% and 96% contrast) 
did not result in any statistically significant difference pre- and post-operatively. This could be 
explained by the low number of patients. Patients’ pupils were also dilated at the time of 










Retinal hemodynamic assessment is a promising approach to study the pathophysiology of the 
ocular diseases and has the potential to play a key role in early diagnosis as there is increasing 
evidence that vascular pathologies play a pivotal role in the etiology and progression of number 
of ophthalmic diseases, including glaucoma, age-related macular degeneration, and diabetic 
retinopathy2;20;21. Our laboratory has shown reduced retinal vascular reactivity in diabetic 
patients22-25. Studies in glaucoma patients have shown reduced blood flow to the retinal ganglion 
cells and optic nerve, possibly contributing to the damage seen in glaucomatous optic 
neuropathy21;26;27. Changes in macular retinal capillary blood flow are also documented in age-
related maculopathy28.  
 
There are number of novel instruments developed to assess retinal hemodynamics. Impact of 
lenticular opacity have been widely neglected despite the wide use of these instruments in the 
elderly population when increase in the intraocular light scatter is often observed and 
concomitant cataract is inevitable. In order to investigate the impact of intra-ocular light scatter 
on the CLBF, we first used a simulated light scatter model and subsequently proved our findings 
using real cataract patients, pre and post operatively. 
 
Our light scatter model resulted in an artifactual increase of retinal arteriolar diameter (p<0.0001) 
which in turn led to increased retinal blood flow values (p<0.0001).  Centerline blood velocity, 
however, was not affected by the simulated light scatter. In our second study, retinal arteriolar 
diameter was similarly elevated in the presence of cataract (p<0.022) which in turn led to an 
increase of the derived retinal blood flow values (p<0.028). Centerline blood velocity was not 
significantly affected by light scatter produced by cataract similar to our findings in the first 
study using simulated light scatter.  
 
The densitometry technique that is used by the CLBF to measure vessel diameter is impacted by 
the light scatter induced by cataract. We hypothesize that as light scatter increases, the 
densitometry image of the vessel loses contrast and the slopes of the densitometry profile 
broaden. Ultimately, light scatter will result in breakdown of the CLBF laser tracking system but 
artifactually increased vessel diameter values can be acquired prior to this point. On the other 
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hand, it is clear that the bidirectional laser Doppler velocimetry technique used to measure 
centerline blood velocity is relatively robust to the optical effects of artificial light scatter, 
although the data does reveal a trend (Wilcoxon, p=0.074) for increased velocity in the presence 
of cataract.   
      
In our first study, we showed that using the high intensity laser setting of the CLBF reduced the 
impact of light scatter on the measured diameter values. Nevertheless, we have demonstrated in 
our second study that using the high intensity laser setting of the CLBF still results in erroneous 
hemodynamic measurements in the presence of cataract. The use of the high laser setting was 
necessary in order to allow adequate visualization of the fundus and proper functioning of the 
laser tracking system of the CLBF prior to surgery. 
 
A number of techniques designed to assess retinal vessel diameter, including the Retinal Vessel 
Analyzer37 and the assessment of retinal photographs120, use algorithms that are very similar to 
that used in the CLBF and therefore may be susceptible to artifact resulting from light scatter. 
Cataract is an inevitable consequence of aging and we showed significant change in retinal 
vessel diameter measurements of patients with mild to moderate cataract. Therefore, care needs 
to be exercised in the interpretation of studies of retinal vessel diameter that utilize cohorts with 
age as a co-variable. 
 
Future instrumentation could incorporate a negative feedback loop that automatically increases 
HeNe laser intensity in situations where the slope of the densitometry profile becomes shallow. 
Other instruments such as the new generation of the Stray Light Meter, developed by Van den 
Burg et al 100;102, could also be incorporated into the CLBF and other instruments to allow for a 
quick measurement of patients’ intraocular light scatter on each visit. This measure of the 
intraocular light scatter could be compared with previous readings and in case of any change, the 
instrument could automatically adjust the laser settings or use a mathematical model to correct 
the measured retinal vessel diameter and subsequently blood flow. Another way of dealing with 
the impact of intraocular light scatter change is to use other CLBF parameters that do not rely on 
diameter estimation but still provide useful hemodynamic information, such as centerline blood 
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